You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

DecisionDx-Melanoma

Showing 1 - 25 of 2,503
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cutaneous Melanoma Trial in Atlanta, Louisville, Saint Louis

Terminated
  • Cutaneous Melanoma
    • Atlanta, Georgia
    • +2 more
    Oct 1, 2021

    Cutaneous Melanoma Trial in United States

    Terminated
    • Cutaneous Melanoma
      • Santa Rosa, California
      • +3 more
      Oct 1, 2021

      Iris Melanoma, Medium/Large Size Posterior Uveal Melanoma, Stage IIA Uveal Melanoma Trial in Los Angeles (External Beam

      Terminated
      Has Results
      • Iris Melanoma
      • +6 more
      • External Beam Radiation Therapy
      • Laboratory Biomarker Analysis
      • Los Angeles, California
        Jonsson Comprehensive Cancer Center
      Jul 22, 2020

      Psychoeducation for Uveal Melanoma

      Not yet recruiting
      • Uveal Melanoma
      • Education for Intervention
      • Best Practice
      • (no location specified)
      Oct 4, 2023

      Malignant Melanomas Trial in Fuzhou (Recombinant Human Adenovirus Type 5 Injection)

      Enrolling by invitation
      • Malignant Melanomas
      • Recombinant Human Adenovirus Type 5 Injection
      • Fuzhou, Fujian, China
        Fujian Cancer Hospital, Department of Internal Medicine, Ward 19
      Jul 7, 2023

      Melanoma Trial in Scottsdale (Educational Intervention, Questionnaire Administration)

      Active, not recruiting
      • Melanoma
      • Educational Intervention
      • Questionnaire Administration
      • Scottsdale, Arizona
        Mayo Clinic in Arizona
      Jan 4, 2023

      Blocking TNF to Potentiate ICI-dependent Immune Awakening in

      Recruiting
      • Melanoma
      • +2 more
        • Toulouse, France
          Institut Claudius Regaud
        May 25, 2023

        Uveal Melanoma Trial in Grand Rapids (Darovasertib)

        Recruiting
        • Uveal Melanoma
        • Grand Rapids, Michigan
          The Cancer and Hematology Centers
        Jun 14, 2023

        EVALUATING THE CURRENT STANDARD OF CARE FOR PATIENTS DIAGNOSED

        Not yet recruiting
        • Melanoma (Skin)
        • Melanoma
          • (no location specified)
          Jun 2, 2023

          Melanoma (Skin) Trial in Houston (BMS-986213 (Relatlimab-Nivolumab FDC), Nivolumab, Relatlimab)

          Not yet recruiting
          • Melanoma (Skin)
          • BMS-986213 (Relatlimab-Nivolumab FDC)
          • +2 more
          • Houston, Texas
            M D Anderson Cancer Center
          Feb 1, 2023

          Clinical Stage IIA Cutaneous Melanoma AJCC v8 Trial in Portland (drug, procedure, other)

          Not yet recruiting
          • Clinical Stage IIA Cutaneous Melanoma AJCC v8
          • Portland, Oregon
            OHSU Knight Cancer Institute
          Nov 27, 2023

          A Storage Facility for Tissues Obtained From Malignant Melanoma

          Recruiting
          • Melanoma
          • Biospecimen Collection
          • Columbus, Ohio
            Ohio State University Comprehensive Cancer Center
          Nov 6, 2022

          Immunotherapy Among BRAF-Positive Melanoma Patients Treated in

          Completed
          • Metastatic Melanoma
          • East Hanover, New Jersey
            Novartis Investigative Site
          Nov 11, 2022

          Melanoma (Skin) Trial in Omsk, Saint Petersburg (BCD-201, Keytruda)

          Recruiting
          • Melanoma (Skin)
          • Omsk, Russian Federation
          • +2 more
          Aug 1, 2023

          Metastatic Uveal Melanoma Trial in Philadelphia (Defactinib Hydrochloride, Raf/MEK Inhibitor VS-6766)

          Recruiting
          • Metastatic Uveal Melanoma
          • Defactinib Hydrochloride
          • +2 more
          • Philadelphia, Pennsylvania
            Sidney Kimmel Cancer Center at Thomas Jefferson University
          Jan 23, 2023

          PD-1 Refractory Advanced Melanoma Trial in Pittsburgh (Responder-Derived Fecal microbiota transplantation (R-FMT, Pembrolizumab,

          Not yet recruiting
          • PD-1 Refractory Advanced Melanoma
          • Responder-Derived Fecal microbiota transplantation (R-FMT
          • +2 more
          • Pittsburgh, Pennsylvania
            UPMC Hillman Cancer Center
          Sep 1, 2023

          Gut and Tumor Microbiome in Advanced ER-positive and

          Not yet recruiting
          • Breast Cancer
          • Melanoma
          • Observation
          • (no location specified)
          Nov 6, 2023

          Cutaneous Melanoma Trial in Portland (Training and Education)

          Not yet recruiting
          • Cutaneous Melanoma
          • Training and Education
          • Portland, Oregon
            OHSU Knight Cancer Institute
          Dec 29, 2022

          Immunotherapy in Patients With Metastatic Melanoma

          Not yet recruiting
          • Metastatic Melanoma
          • data collection
          • (no location specified)
          Nov 28, 2022

          Metastatic Melanoma Trial in Germany (molecular tissue analysis)

          Recruiting
          • Metastatic Melanoma
          • molecular tissue analysis
          • Tuebingen, Baden-Württemberg, Germany
          • +13 more
          Feb 28, 2023

          Melanoma Trial in Beijing (IBI363)

          Not yet recruiting
          • Melanoma
          • IBI363
          • Beijing, Beijing, China
            Beijing Cancer Hospital
          Oct 7, 2023

          Metastatic Melanoma, Stage III Cutaneous Melanoma AJCC v7, Stage IV Cutaneous Melanoma AJCC v6 and v7 Trial in Houston

          Active, not recruiting
          • Metastatic Melanoma
          • +2 more
          • Aldesleukin
          • +6 more
          • Houston, Texas
            M D Anderson Cancer Center
          Aug 18, 2022

          Tumor Skin, Metastatic Melanoma, Melanoma Trial in Orlando, Louisville (OBX-115)

          Active, not recruiting
          • Tumor Skin
          • +2 more
          • OBX-115
          • Orlando, Florida
          • +1 more
          Sep 28, 2023

          Monitoring T Cell Responses in Melanoma, Lung and Other Cancer

          Recruiting
          • Clinical Stage III Cutaneous Melanoma AJCC v8
          • +9 more
          • Biospecimen Collection
          • Electronic Health Record Review
          • Rochester, Minnesota
            Mayo Clinic in Rochester
          Oct 4, 2023

          Melanoma and Vitiligo Trial in Nice (Biospecimen into patients who had skin diseases)

          Recruiting
          • Melanoma and Vitiligo
          • Biospecimen into patients who had skin diseases
          • Nice, Provence Alpes Cote d'Azur, France
            CHU de Nice
          Jan 23, 2023